08/09/2021Journal articleEffectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in five countriesThis study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes. This case-control design can be used by national malaria…08/09/2021
This study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes. This case-control design can be used by national malaria control programmes at intervals to confirm that SMC remains effective.
07/06/2021Journal articleReactive, self-administered malaria treatment against asymptomatic malaria infection: Results of a cluster randomised controlled trial in The GambiaSelectively targeting and treating malaria-infected individuals may further decrease parasite carriage in low-burden settings. Using a trans-disciplinary approach, a reactive treatment strategy to reduce prevalence in participating communities was co-developed…07/06/2021
Selectively targeting and treating malaria-infected individuals may further decrease parasite carriage in low-burden settings. Using a trans-disciplinary approach, a reactive treatment strategy to reduce prevalence in participating communities was co-developed and tested.
29/01/2021Journal articleSeasonal malaria chemoprevention in the Sahel subregion of Africa: A cost-effectiveness and cost-savings analysisThis study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country seasonal malaria chemoprevention campaign. 29/01/2021
This study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country seasonal malaria chemoprevention campaign.
05/12/2020Journal articleEffectiveness of seasonal malaria chemoprevention at scale in west and central Africa: An observational studyThis study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016. These results represent the first large-scale evaluation of SMC implemented by…05/12/2020
This study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016. These results represent the first large-scale evaluation of SMC implemented by national programmes, and provide evidence of impact on malaria deaths.
28/01/2019Learning paperSeasonal chemoprevention as an effective malaria preventive strategy for children in the SahelThis paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal…28/01/2019
This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal malaria chemoprevention (SMC) scale-up. By supporting national malaria control/elimination programmes…
21/09/2018Advocacy briefMalaria Consortium and the Sustainable Development GoalsThis brochure highlights some of the key ways in which Malaria Consortium is contributing to the Sustainable Development Goals and illustrates the importance of using a multifaceted approach to improve…21/09/2018
This brochure highlights some of the key ways in which Malaria Consortium is contributing to the Sustainable Development Goals and illustrates the importance of using a multifaceted approach to improve health outcomes globally.
04/05/2018PresentationScaling up access to seasonal malaria chemoprevention in the SahelDiego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an…04/05/2018
Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an estimated gap of 12 to 18 million children who could…
28/02/2018NewsletterA catalyst project comes to an endThrough ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s…28/02/2018
Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s lives across seven countries in the Sahel. This final newsletter…
29/11/2017Project briefSauver des vies – la CPS à grande échelleLe paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la…29/11/2017
Le paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la chimioprévention du paludisme saisonnier (CPS) à grande échelle. La CPS,…
13/11/2017Technical briefSeasonal malaria chemoprevention at scale: Saving livesMalaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal…13/11/2017
Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal malaria chemoprevention at scale. An estimated gap of 12 to…
29/09/2017NewsletterACCESS-SMC September 2017 newsletterMalaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted.…29/09/2017
Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted. Read about the major strides the ACCESS-SMC project is making…
03/02/2017Annual reviewMalaria Consortium strategy 2015–2019To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest…03/02/2017
To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest and most marginalised. We will target key health burdens, including…
10/01/2017Learning briefSeasonal malaria chemoprevention: Transforming the malaria landscape in the SahelACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and…10/01/2017
ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and its impact on reducing malaria in children under five across…
20/11/2016Annual reviewTrustees report and financial statements for the year to 31 March 2016Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements…20/11/2016
Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements 2015–2016.
20/11/2016Annual reviewHighlights from the trustees report and financial statements 2015–2016During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat…20/11/2016
During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health. This review…
08/06/2016Advocacy briefMaking the case for seasonal malaria chemopreventionSeasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the…08/06/2016
Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the Sahel region, discusses the challenges to successful scale-up, and presents…